1. Apoptosis
  2. Thymidylate Synthase Apoptosis
  3. LC1343

LC1343 is a human thymidylate synthase (hTS) inhibitor with an IC50 of 7 μM. LC1343 inhibits cancer cell growth and induces apoptosis in cancer cells. LC1343 can be used for the research of ovarian cancer, colorectal cancer, and pancreatic cancer.

For research use only. We do not sell to patients.

LC1343

LC1343 Chemical Structure

CAS No. : 2756347-51-8

Size Stock
50 mg   Get quote  
100 mg   Get quote  
250 mg   Get quote  

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Top Publications Citing Use of Products
  • Biological Activity

  • Purity & Documentation

  • References

  • Customer Review

Description

LC1343 is a human thymidylate synthase (hTS) inhibitor with an IC50 of 7 μM. LC1343 inhibits cancer cell growth and induces apoptosis in cancer cells. LC1343 can be used for the research of ovarian cancer, colorectal cancer, and pancreatic cancer[1][2].

In Vitro

LC1343 (72 h) potently inhibits the growth of A2780 ovarian, A2780/CP cisplatin-resistant ovarian, and HCT116 colorectal cancer cells with IC50 values of 11 μM, 18.8 μM, and 24.6 μM, respectively[1].
LC1343 (7-11 μM; 72 h with electroporation) has its cytotoxicity synergistically enhanced by electroporation in A2780 ovarian cancer cells, increasing growth inhibition from 29.5% to 62.5% at 7 μM and from 49.1% to 71.7% at 11 μM, with SQ values of 1.83 and 1.33, respectively[1].
LC1343 (5-16 μM; 72 h with electroporation) has its cytotoxicity enhanced by electroporation in A2780/CP cisplatin-resistant ovarian cancer cells, increasing growth inhibition from 24.9% to 61.7% at 5 μM and from 47.1% to 66.0% at 16 μM[1].
LC1343 (10-30 μM; 72 h with electroporation) has its cytotoxicity strongly synergistically enhanced by electroporation in HCT116 colorectal cancer cells, increasing growth inhibition from 6.1% to 35.5% at 10 μM and from 44.7% to 64.4% at 30 μM[1].
LC1343 inhibits growth of multiple cancer cell lines, including 5-FU (HY-90006)-resistant LPc167 pancreatic adenocarcinoma cells with high hTS levels, and exhibits consistent activity against PDAC-2 and PDAC-5 pancreatic adenocarcinoma cells[2].
LC1343 induces apoptotic cell death in Cisplatin (HY-17394)-sensitive A2780 and Cisplatin-resistant A2780/CP gynecological cancer cells[2].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Cytotoxicity Assay[1]

Cell Line: A2780 (cisplatin-sensitive ovarian carcinoma)
Concentration: 7; 11 μM
Incubation Time: 72 h (with electroporation)
Result: Caused 29.5% cell growth inhibition alone at 7 μM, which increased to 62.5% with electroporation.
Caused 49.1% cell growth inhibition alone at 11 μM, which increased to 71.7% with electroporation.

Cell Cytotoxicity Assay[1]

Cell Line: A2780/CP (cisplatin-resistant ovarian carcinoma)
Concentration: 5; 16 μM
Incubation Time: 72 h (with electroporation)
Result: Caused 24.9% cell growth inhibition alone at 5 μM, which increased to 61.7% with electroporation.
Caused 47.1% cell growth inhibition alone at 16 μM, which increased to 66.0% with electroporation.

Cell Cytotoxicity Assay[1]

Cell Line: HCT116 (colorectal adenocarcinoma)
Concentration: 10; 30 μM
Incubation Time: 72 h (with electroporation)
Result: Caused 6.1% cell growth inhibition alone at 10 μM, which increased to 35.5% with electroporation.
Caused 44.7% cell growth inhibition alone at 30 μM, which increased to 64.4% with electroporation.

Cell Cytotoxicity Assay[1]

Cell Line: A2780 (cisplatin-sensitive ovarian carcinoma), HCT116 (colorectal adenocarcinoma)
Concentration: 7; 10 μM
Incubation Time: 72 h (with electroporation)
Result: In A2780 cells, the combination with carboplatin caused 43.45% growth inhibition alone, which increased to 84.70% with electroporation.
In A2780 cells, the combination with Cisplatin caused 55.11% growth inhibition alone, which increased to 73.30% with electroporation.
In A2780 cells, the combination with Oxaliplatin (HY-17371) caused 69.30% growth inhibition alone, which increased to 82.75% with electroporation.
In HCT116 cells, the combination with Cisplatin caused 29.39% growth inhibition alone, which increased to 45.00% with electroporation.
Molecular Weight

499.58

Formula

C22H17N3O5S3

CAS No.
SMILES

O=C(NC1=NC2=CC=C(S(=O)(C)=O)C=C2S1)C(C3=CC=CC=C3)SC4=CC=C([N+]([O-])=O)C=C4

Shipping

Room temperature in continental US; may vary elsewhere.

Storage

Please store the product under the recommended conditions in the Certificate of Analysis.

Purity & Documentation
References
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.
  • Molarity Calculator

  • Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass   Concentration   Volume   Molecular Weight *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product Name

 

Requested Quantity *

Applicant Name *

 

Salutation

Email Address *

 

Phone Number *

Department

 

Organization Name *

City

State

Country or Region *

     

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
LC1343
Cat. No.:
HY-184155
Quantity:
MCE Japan Authorized Agent: